-
EP1328526
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1328526
| EP1328526 - 3,8-DIAZABICYCLO 3.2.1 OCTANES AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS [Right-click to bookmark this link] | |||
| Former [2003/30] | 3,8-DIAZABICYCLO[3.2.1]OCTANES AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS | ||
| [2007/45] | Status | The application has been refused Status updated on 21.07.2006 Database last updated on 22.08.2024 | Most recent event Tooltip | 05.10.2007 | Change - German title | published on 07.11.2007 [2007/45] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2003/30] | Inventor(s) | 01 /
BJÖRSNE, Magnus AstraZeneca R & D Mölnda S-431 83 Mölndal / SE | 02 /
HOFFMANN, Kurt-Jürgen AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | 03 /
PONTEN, Fritiof AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | 04 /
STRANDLUND, Gert AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | 05 /
SVENSSON, Peder Nordenskiöldsgatan 12 S-413 09 Göteborg / SE | 06 /
WILSTERMANN, Michael AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | [2003/30] | Application number, filing date | 01977023.9 | 18.10.2001 | [2003/30] | WO2001SE02294 | Priority number, date | SE20000003795 | 20.10.2000 Original published format: SE 0003795 | [2003/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0232902 | Date: | 25.04.2002 | Language: | EN | [2002/17] | Type: | A1 Application with search report | No.: | EP1328526 | Date: | 23.07.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.04.2002 takes the place of the publication of the European patent application. | [2003/30] | Search report(s) | International search report - published on: | SE | 25.04.2002 | Classification | IPC: | C07D487/08, A61K31/495, A61P9/06 | [2003/30] | CPC: |
C07D487/08 (EP,US);
A61K31/495 (EP,US);
A61P9/06 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/30] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | 3,8-DIAZABICYCLO 3.2.1 OCTANE UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON HERZRHYTHMUSSTÖRUNGEN | [2007/45] | English: | 3,8-DIAZABICYCLO 3.2.1 OCTANES AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS | [2007/45] | French: | 3,8-DIAZABICYCLO 3.2.1 OCTANES ET LEUR UTILISATION DANS LE TRAITEMENT D'ARYTHMIES CARDIAQUES | [2007/45] |
| Former [2003/30] | 3,8-DIAZABICYCLO[3.2.1]OCTANE UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON HERZRHYTHMUSSTÖRUNGEN | ||
| Former [2003/30] | 3,8-DIAZABICYCLO[3.2.1]OCTANES AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS | ||
| Former [2003/30] | 3,8-DIAZABICYCLO[3.2.1]OCTANES ET LEUR UTILISATION DANS LE TRAITEMENT D'ARYTHMIES CARDIAQUES | Entry into regional phase | 20.05.2003 | National basic fee paid | 20.05.2003 | Designation fee(s) paid | 20.05.2003 | Examination fee paid | Examination procedure | 15.05.2002 | Request for preliminary examination filed International Preliminary Examining Authority: SE | 20.05.2003 | Examination requested [2003/30] | 17.02.2005 | Despatch of a communication from the examining division (Time limit: M06) | 26.08.2005 | Reply to a communication from the examining division | 01.03.2006 | Cancellation of oral proceeding that was planned for 10.03.2006 | 01.03.2006 | Minutes of oral proceedings despatched | 10.03.2006 | Date of oral proceedings (cancelled) | 10.04.2006 | Despatch of communication that the application is refused, reason: substantive examination [2006/34] | 20.04.2006 | Application refused, date of legal effect [2006/34] | Fees paid | Renewal fee | 31.10.2003 | Renewal fee patent year 03 | 02.11.2004 | Renewal fee patent year 04 | 31.10.2005 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9518129 (PFIZER [US], et al); | [X]WO0059510 (PFIZER PROD INC [US], et al); | [A]WO9523152 (RIACE ETS [LI], et al); | [A]WO9635686 (RHONE POULENC RORER SA [FR], et al) | [A] - G. CIGNARELLA ET AL., "Benzocondensed derivatives as rigid analogues of the mu-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo(3.2.1)octanes: Synthesis, modeling and affinity", II FARMACO, (1998), vol. 53, pages 667 - 674, XP002906803 DOI: http://dx.doi.org/10.1016/S0014-827X(98)00084-6 | [A] - DANIELA BARLOCCO ET AL., "Mono- and disubstituted-3,8-diazabicyclo(3.2.1)octane derivatives as analgesics structurally related to epibatidine: Synthesis, activity and modeling", J. MED. CHEM., (1998), vol. 41, pages 674 - 681, XP002906804 DOI: http://dx.doi.org/10.1021/jm970427p | [A] - D. BARLOCCO ET AL., "Synthesis and mu-opioid receptor affinity of a new series of nitro substituted 3,8-diazabicyclo(3.2.1)octane derivatives", II FARMACO, (1998), vol. 53, pages 557 - 562, XP002906805 DOI: http://dx.doi.org/10.1016/S0014-827X(98)00065-2 |